NovaVitality

NovaVitality

The Current UK Regulatory Position on Retatrutide

Published by NovaVitality – RUO Peptides, Rigorously Verified, Responsibly Supplied A Clear Warning from the MHRA In a recent enforcement action, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) uncovered a large-scale operation illegally manufacturing and distributing unlicensed injectable…

What is Retatrutide?

Is Retatrutide (Triple Incretin Agonist) the Next-Gen Research Compound? Retatrutide is a synthetic investigational peptide developed as a triple agonist of the GIP, GLP-1, and glucagon receptors. By activating all three incretin pathways simultaneously, it represents the next generation of incretin-based research…